Cardiomyocytes
Built For This Cell Type.
Expansion, mesoderm induction and differentiation run in the same bioreactor, removing the transfers that cost yield and add contamination risk.
The growth-factor-based process yields ventricular and atrial cardiomyocytes rather than a single lineage.
Cells were characterised by electrophysiology, force generation and transplantation studies rather than by marker expression alone.
Applications
- Directed differentiation
- Aggregate culture
- hiPSC / PSC expansion
- Disease modeling
- Drug & tox screening
Systems for This Cell Type
Each system carries the note explaining why it suits this cell type.
- PBS-MiniDifferentiation process development
- PBS-MiniPROScale-up to 500 mL (demonstrated)
A growth-factor-based process produced ventricular and atrial cardiomyocytes from human pluripotent stem cells in Vertical-Wheel® bioreactors, integrating expansion, mesoderm induction and differentiation, scaling to 500 mL, with function validated by electrophysiology, force generation and transplantation.
The Data Behind It.
No documents are tagged for this cell type yet.
Talk Through Your Process.
Our scientists work on these processes daily. Bring us your cell type, your scale and your constraints.